Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | EVP Chief Legal Compliance Off | September 15, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,885 |
Reported balance
After 2026-09-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-15 · Sale · Disposed 1,700 · Balance 99,885 F1: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2: Included in this number are 71,903 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 83 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan.
F2: Included in this number are 71,903 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 83 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 20:25 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,700 | $84.04 | $142,868.00 |
DisclosureSEC source: 0001093557-26-000178 · wk-form4_1789590332.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Compliance Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,885 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2 · balance_after: Included in this number are 71,903 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 83 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. Read SEC document |
| August 22, 2026 Filed Aug 25, 2026 20:14 UTC | DEXCOM INC DXCM · Entity 3114 | Tax withholdingCommon Stock | 1,451 | $92.34 | $133,985.34 |
DisclosureSEC source: 0001093557-26-000157 · wk-form4_1787688876.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Compliance Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,502 F1 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. F2 · balance_after: Included in this number are 71,903 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 5,699 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:08 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,700 | $91.93 | $156,281.00 |
DisclosureSEC source: 0001093557-26-000149 · wk-form4_1786997293.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Compliance Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,953 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2 · balance_after: Included in this number are 74,753 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 8,549 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 21:06 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,700 | $74.42 | $126,514.00 |
DisclosureSEC source: 0001093557-26-000135 · wk-form4_1784235969.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Compliance Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,653 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2 · balance_after: Included in this number are 74,753 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 8,549 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:32 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,700 | $75.55 | $128,435.00 |
DisclosureSEC source: 0001093557-26-000131 · wk-form4_1781728348.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Compliance Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,353 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2 · balance_after: Included in this number are 74,753 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 8,549 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:39 UTC | DEXCOM INC DXCM · Entity 3114 | Tax withholdingCommon Stock | 1,451 | $71.90 | $104,326.90 |
DisclosureSEC source: 0001093557-26-000098 · wk-form4_1779914348.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Compliance Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,053 F1 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. F2 · balance_after: Included in this number are 74,753 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 8,549 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:34 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,700 | $59.91 | $101,847.00 |
DisclosureSEC source: 0001093557-26-000087 · wk-form4_1779222866.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,504 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2 · balance_after: Included in this number are 77,603 unvested RSUs, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 23:27 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,700 | $63.04 | $107,168.00 |
DisclosureSEC source: 0001093557-26-000065 · wk-form4_1776382026.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,204 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5- 1 Plan. F2 · balance_after: Included in this number are 77,603 unvested RSUs, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:07 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,700 | $64.85 | $110,245.00 |
DisclosureSEC source: 0001093557-26-000052 · wk-form4_1773864421.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,904 F1 · shares: On November 26, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 77,603 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC | DEXCOM INC DXCM · Entity 3114 | Tax withholdingCommon Stock | 23,325 | $68.10 | $1,588,432.50 |
DisclosureSEC source: 0001093557-26-000048 · wk-form4_1773172906.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,604 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 77,603 unvested RSUs, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 255 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 20:01 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 39,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000048 · wk-form4_1773172906.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,929 F1 · shares: Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC | DEXCOM INC DXCM · Entity 3114 | Tax withholdingCommon Stock | 2,653 | $73.36 | $194,624.08 |
DisclosureSEC source: 0001093557-26-000010 · wk-form4_1770068784.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,655 F2 · shares: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person. F3 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026, and 83 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 21:46 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 7,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000010 · wk-form4_1770068784.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,308 F1 · shares: Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 21:56 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $80.29 | $40,145.00 |
DisclosureSEC source: 0001093557-25-000247 · wk-form4_1755554185.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,102 F1 · shares: On February 21, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:03 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $86.03 | $43,015.00 |
DisclosureSEC source: 0001093557-25-000226 · wk-form4_1752782579.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,602 F1 · shares: On February 21, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:31 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $82.80 | $41,400.00 |
DisclosureSEC source: 0001093557-25-000217 · wk-form4_1750278680.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,102 F1 · shares: On February 21, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| May 23, 2025 Filed May 28, 2025 20:50 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 10,000 | $84.28 | $842,849.00 |
DisclosureSEC source: 0001093557-25-000197 · wk-form4_1748465396.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,602 F1 · shares: On February 21, 2025, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $83.66 to $84.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 12, 2025 Filed Mar 14, 2025 21:25 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 13,000 | $70.38 | $914,941.30 |
DisclosureSEC source: 0001093557-25-000080 · wk-form4_1741987520.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,602 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 08, 2025 Filed Mar 11, 2025 23:17 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 22,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000063 · wk-form4_1741735024.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,602 F2 · shares: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting from the date of grant as follows: 1/2 shall vest on March 8, 2026, 1/8 shall vest on May 22, 2026, 1/8 shall vest on August 22, 2026, 1/8 shall vest on November 8, 2026, and the remaining balance shall vest on March 8, 2027. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F3 · balance_after: Included in this number are 86,490 unvested restricted stock units, 29,922 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 14,474 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 12,040 of which were granted on March 8, 2022 and shall vest through March 8, 2026, and 246 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on February 28, 2025. Read SEC document |
| March 08, 2025 Filed Mar 11, 2025 23:17 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 29,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000063 · wk-form4_1741735024.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,804 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. Read SEC document |
| August 30, 2024 Filed Sep 3, 2024 20:22 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 686 | $70.00 | $48,020.00 |
DisclosureSEC source: 0001093557-24-000150 · wk-form4_1725394928.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,636 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026, and 73 shares acquired under the issuers 2015 Employee Stock Purchase Plan on August 30, 2024. Read SEC document |
| July 31, 2024 Filed Aug 1, 2024 23:23 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 652 | $69.55 | $45,346.60 |
DisclosureSEC source: 0001093557-24-000147 · wk-form4_1722554576.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,249 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| June 28, 2024 Filed Jun 28, 2024 21:34 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 659 | $114.29 | $75,317.11 |
DisclosureSEC source: 0001093557-24-000135 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,901 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| May 31, 2024 Filed May 31, 2024 21:27 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 652 | $119.24 | $77,744.48 |
DisclosureSEC source: 0001093557-24-000123 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,560 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| April 30, 2024 Filed May 2, 2024 21:07 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 629 | $126.25 | $79,411.25 |
DisclosureSEC source: 0001093557-24-000081 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,212 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026, and 159 shares purchased pursuant to the DexCom, Inc. 2015 Employee Stock Purchase Plan. Read SEC document |
| March 28, 2024 Filed Mar 29, 2024 23:30 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 100 | $140.73 | $14,073.00 |
DisclosureSEC source: 0001093557-24-000060 · edgardoc.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,682 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 28, 2024 Filed Mar 29, 2024 23:30 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,524 | $140.02 | $353,399.37 |
DisclosureSEC source: 0001093557-24-000060 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,782 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $139.56 to $140.407. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:39 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 8,799 | $134.41 | $1,182,679.75 |
DisclosureSEC source: 0001093557-24-000048 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,306 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 22:30 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 21,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-24-000034 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,105 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 60,303 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 24,080 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:10 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,170 | $115.42 | $135,043.74 |
DisclosureSEC source: 0001093557-23-000238 · edgardoc.xml · nonDerivative · entry 3 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,394 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $115.10 to $115.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:10 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,542 | $114.43 | $176,451.52 |
DisclosureSEC source: 0001093557-23-000238 · edgardoc.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,564 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $114.035 to $115.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:10 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 900 | $113.64 | $102,278.79 |
DisclosureSEC source: 0001093557-23-000238 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,106 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan which was amended on August 29, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $113.20 to $114.01. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 253 | $116.03 | $29,355.59 |
DisclosureSEC source: 0001093557-23-000095 · edgardoc.xml · nonDerivative · entry 3 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,870 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 950 | $115.08 | $109,329.52 |
DisclosureSEC source: 0001093557-23-000095 · edgardoc.xml · nonDerivative · entry 2 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,123 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F4 · price: This transaction was executed in multiple trades at prices ranging from $114.70 to $115.45. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:56 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,409 | $114.07 | $274,804.99 |
DisclosureSEC source: 0001093557-23-000095 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,073 F1 · shares: On December 15, 2022, Mr. Brown adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Brown. The shares set forth above were sold pursuant to the 10b5-1 Plan that was intended to comply with prior version of Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $113.63 to $114.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:46 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 4,812 | $111.40 | $536,051.99 |
DisclosureSEC source: 0001093557-23-000076 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,482 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:02 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 21,769 | $0.00 | $21.77 |
DisclosureSEC source: 0001093557-23-000060 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,294 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 57,885 unvested restricted stock units. 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 36,116 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 00:23 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 12,038 | $0.00 | $12.04 |
DisclosureSEC source: 0001093557-22-000046 · edgardoc.xml · nonDerivative · entry 1 Brown Michael Jon · CIK 0001899922 · EVP Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,038 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 12,038 unvested restricted stock units, 12,038 of which were granted on March 8, 2022 and shall vest through March 8, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.